Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00569270 · ClinicalTrials.gov registry record · Phase 4
Dynamic Hyperinflation and Tiotropium
A Phase 4 study, sponsored by Gelb, Arthur F., M.D..
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00569270 is a Phase 4 study that has completed, run by Gelb, Arthur F., M.D.. The registered enrollment target is 30 participants.
The verdict
NCT00569270, a Phase 4 study, has completed, sponsored by Gelb, Arthur F., M.D..
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
We will detect dynamic hyperinflation (DH) in 40 COPD (chronic obstructive pulmonary disease) patients with moderately severe disease using metronome paced hyperventilation (MPH) with inspiratory capacity as the primary end point. Hypothesis: Is tiotropium capable of lung volume protecting inspiratory capacity from MPH induced DH vs placebo in a randomized crossover double blinded study.
Interventions
- DRUG Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-10 |
| Est. Completion | 2009-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00569270
The ClinicalTrials.gov registry entry for NCT00569270 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gelb, Arthur F., M.D., which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Placebo is the first listed.
NCT00569270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00569270 about?
NCT00569270 is a clinical study titled "Dynamic Hyperinflation and Tiotropium". We will detect dynamic hyperinflation (DH) in 40 COPD (chronic obstructive pulmonary disease) patients with moderately severe disease using metronome paced hyperventilation (MPH) with inspiratory capacity as the primary end point. Hypothesis: Is tiotropium capable of lung volume protecting inspirato...
What is the current status of trial NCT00569270?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2006-10. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00569270?
The interventions under investigation include: Placebo (DRUG).
Who is sponsoring clinical trial NCT00569270?
This trial is sponsored by Gelb, Arthur F., M.D., which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.